BioLargo extends CFO Charles Dargan's engagement through Jan 2024; grants option for 300,000 shares

BIOLARGO, INC.

CFO Charles K. Dargan II's engagement extended one year to January 31, 2024.
Compensation: option to purchase 300,000 shares of common stock at $0.20/share.
Option vests monthly (25,000 shares/month) starting March 21, 2023; expires in 10 years.
No cash compensation; CFO eligible for business expense reimbursement (historically not requested).
Prior extension expired January 31, 2023; agreement may be terminated on 30 days' notice.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.